drugset / Trial / NCT02201849

A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults

NCT02201849

Phase 1 Completed 104 enrolled Biogen
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the safety, tolerability, and pharmacokinetics of ALKS 8700, a monomethyl fumerate (MMF) molecule.

Timeline

Start
2014-07
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Diroximel fumarate Small molecule Oral
Comparator dimethyl fumarate Unknown Oral

Indications